these results show that 8F4 is highly active against treatment-refractory primary human HLA-A2 + AML in established AML treatment NSG model. 8F4 treatment prolongs survival of mice with ...

The Jackson Laboratory imported the strain in 2015 in anticipation of distribution, but has since discontinued production of MISTRG mice. Fortunately for the research community, both the NSG ...

At issue in the lawsuit is MARC’s purchases from JAX of NOD-scid gamma (NSG™) mice, created by JAX by introducing genetic mutations into its nonobese diabetic (NOD) mice. NSG mice are severely ...